Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substanceShalin Shah, CEO of Marius Pharmaceuticals, has been advocating for less stringent regulation of TRT therapy, arguing that the evidence is clear about clinical benefits for men who either produce less […]
